Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of Texas Southwestern Medical Center
About this trial
The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation therapy provides better lung expansion and may improve lung recovery after surgery.
Eligibility criteria
Qualifiers
Age 18 years and older
Admitted to Cardiovascular ICU (CVICU) after coronary artery bypass grafting (CABG), isolated valve repair/replacement, or CABG + valve repair/replacement
Cardiac surgery performed via median sternotomy
Disqualifiers
BMI>40
Refusal to be consented
Prior or current lung transplant patients
Trial design
Treatments tested in this trial
- EzPAP
- Metaneb
- Intermittent Positive Pressure Breathing (IPPB)
Treatment groups
324 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov